Pages
Ads
Categories
- Allergies pills
- Anthelmintics
- Anti Convulsants Pills
- Anti Depressants Pills
- Antibiotics Pills
- AntiViralPill
- Arthritis pills
- Blood Pressure Pills
- Cholesterol Pills
- Diabetes Pills
- Diuretics pills
- eBook download
- Erectile Dysfunction Pills
- Gastrointestinal Pills
- Heartburn Pills
- herbal
- Hypertension pills
- Images pills
- Inflammatory
- Mens Health pills
- Muscle Relaxant Pills
- News
- Other pills
- Pain Relief Pills
- Review prices
- Skin Care Pills
- Stop Smoking Pills
- Uncategorized
- Video about ED pills
- Weight Loss Pills
- Women's Health Drugs
Blogroll
- Acomplia blog
- Advanced whois
- Buy Generic Zofran (Ondansetron)
- Buy Pills Online
- Cialis vs Levitra
- Diet Recipes Blog
- Flexyx A-Z drugs
- Generic Cialis soft tabs
- German drugstore
- Health News and Articles
- Health Signal
- Home Health Agencies
- Italian drugstore
- Natural Weight Loss
- Net Pharmacy
- Spanish drugstore
- The Canadian Rx Drugs
- Traumatology and Orthopaedics
- Viagra Mastercard
- Viagra Without Prescription
- FDA Approves Bayer HealthCare's Kogenate FS Treatment for Routine Prophylaxis in Children with Hemophilia A
- FDA Approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania in the US
- FDA Approves New Injection Site for Risperdal Consta for Schizophrenia Treatment
- Watson Receives US FDA Approval for Rapaflo (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
- Akorn, Inc. Announces the FDA Approval of Akten Ophthalmic Gel 3.5%
- U.S. Food & Drug Administration Approved the use of Reyataz (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
- FDA Grants Lilly's Alimta (Pemetrexed for Injection) Third U.S. Approval
- Boston Scientific Announces FDA Approval of TAXUS Express2 Atom Stent System, First Drug-Eluting Stent For Small Vessels
- Teva's ProAir HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication
- FDA Approves Nasacort AQ Nasal Spray for Children Aged 2-5 years old
Tags
ads
Universal flu
January 5, 2008
A single jab that could give lifelong protection against all types of flu has produced promising results in human trials.
The vaccine, made by Acambis, should protect against all strains of influenza A - the cause of pandemics. Currently, winter flu jabs have to be regularly redesigned because the flu virus keeps changing.
The new vaccine would overcome this and could be stockpiled in advance of a bird flu outbreak, say experts.
Each year winter flu kills around 4,000 people in the UK. Globally, between 500,000 and one million people die each year from influenza. But a pandemic of the human form of bird flu, which experts believe is inevitable, could kill as many as 50m people worldwide. The US trials show that the jab is safe and it works fast to make the body immune against flu. Nine out of 10 of those who had two doses of the jab ACAM-FLU-A developed antibodies against flu virus. Scientists at Acambis are now working to perfect the formulation before doing larger human trials. Dr Michael Watson of Acambis said: “As a universal vaccine, ACAM-FLU-A can potentially overcome many of the drawbacks of existing influenza vaccines. “It can be manufactured at any time of the year, and could be stockpiled in advance of a pandemic or potentially used routinely to ensure population protection against future pandemics.”
Unique action
Current flu vaccines work by giving immunity to two proteins called haemagglutinin and neuraminidase, which are found on the surface of flu viruses. However, these proteins keep mutating which means doctors have to keep making new vaccines to keep up. The Acambis vaccine homes in on a different protein, called M2, which is found on the surface of all A-strains of flu and does not appear to mutate so readily. Professor Ian Jones, a University of Reading virologist, said the jab could end the scramble to produce a new winter jab each year. But he said it would still be some years before it was widely available for patients. “Larger trials and tests on a wider range of viruses will be needed before the full potential for pandemic protection can be assured,” he said.
Posted in: AntiViralPill, News | |
No Comments »
No comments yet.
Fatal error: Call to undefined function: post_comments_feed_link() in /usr/home/drugrxus/domains/drugrxus.com/public_html/news/wp-content/themes/apple/comments.php on line 29
The vaccine, made by Acambis, should protect against all strains of influenza A - the cause of pandemics. Currently, winter flu jabs have to be regularly redesigned because the flu virus keeps changing.